Intended for healthcare professionals

Research

Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.38753.375324.7C (Published 09 March 2006) Cite this as: BMJ 2006;332:571
  1. Martyn J Parker, research fellow (martyn.parker{at}pbh-tr.nhs.uk)1,
  2. William J Gillespie, dean2,
  3. Lesley D Gillespie, research fellow3
  1. 1 Orthopaedic Department, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough District Hospital, Peterborough PE3 6DA
  2. 2 Hull York Medical School, University of Hull, Hull HU6 7RX
  3. 3 Department of Health Sciences, University of York, Heslington, York YO10 5DD
  1. Correspondence to: M J Parker
  • Accepted 10 January 2006

Abstract

Objectives To present the updated results of systematic review of the current evidence for the effectiveness of hip protectors from reports of completed randomised trials, and to explore the evolution of that evidence.

Design Systematic review with meta-analysis.

Data sources Cochrane Bone, Joint, and Muscle Trauma Group trials register (January 2005), Cochrane central register of controlled trials (Cochrane Library Issue 1, 2005), Medline (1966 to January 2005), Embase (1988 to January 2005), and CINAHL (1982 to December 2004). Other databases and reference lists of relevant articles were searched and some trialists were contacted.

Review methods Randomised or quasirandomised controlled trials reporting the incidence of hip fractures, pelvic fractures, and other fractures in elderly people offered hip protectors compared with a control group that was not.

Results Outcomes for fracture were available from 14 randomised and quasirandomised trials. Pooling of data from 11 trials carried out in nursing or residential care settings, including six cluster randomised studies, showed evidence of a marginally statistically significant reduction in incidence of hip fracture (relative risk 0.77, 95% confidence interval 0.62 to 0.97). Pooling of data from three individually randomised trials of 5135 community dwelling participants showed no reduction in hip fracture incidence with provision of hip protectors (1.16, 0.85 to 1.59). No evidence was found of any significant effect of hip protectors on incidence of pelvic or other fractures. No important adverse effects of hip protectors were reported, but compliance, particularly in the long term, was poor.

Conclusions On the basis of early reports of randomised trials, hip protectors were advocated. Accumulating evidence indicates that hip protectors are an ineffective intervention for those living at home and that their effectiveness in an institutional setting is uncertain.

Footnotes

  • Embedded Image Details of included studies are onbmj.com

  • Contributors All authors designed the study, reviewed the studies identified, and checked the data. MJP wrote the first draft of the article, and WJG and LDG provided substantive subsequent contributions. MJP is guarantor.

  • Funding None.

  • Competing interests None declared.

  • Ethical approval Not required.

View Full Text